Rissphar SPRL
Ouverture de faillite 1.7 FTERissphar reported total assets of €1.93m at the end of the 2021 financial year (annual accounts filed with the NBB on 12 Jul 2022), with 1.7 full-time equivalent.
The score of Rissphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2021
Change 2018 → 2021: Equity +197 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rissphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2021filed on 12 Jul 2022
- Year ended 31 Dec 2020filed on 14 Jul 2021
- Year ended 31 Dec 2019filed on 24 Aug 2020
- Year ended 31 Dec 2018filed on 29 Aug 2019
Rissphar's financial analysis
- Solvency21.7%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rissphar
Rissphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0678.429.579
- VAT number
- BE0678429579
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 10 Jul 2017
- Registered office
- 7812 Ath
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2021 · filed on 12 Jul 2022
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Rissphar (SPRL) has been based in Ath since 2017, active in: retail sale of pharmaceutical products. For 2021, it reports a net profit of 139,285 € and equity of 418,020 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 21.7%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Rissphar
Companies in the same business, of comparable size and area, outside its group.
- Pharma Bury & Co Retail sale of pharmaceutical products Anderlues · balance sheet €1.63m
- Apotheek Goddeeris Retail sale of pharmaceutical products Genk · balance sheet €1.41m
- JLV Consult Retail sale of pharmaceutical products Thuin · balance sheet €2.53m
- Idespharma Retail sale of pharmaceutical products Koksijde · balance sheet €1.34m
- Pharmacie Herbint Retail sale of pharmaceutical products Evere · balance sheet €1.83m
- Pharmarive Retail sale of pharmaceutical products Etterbeek · balance sheet €1.80m
- Saarbach Dino Retail sale of pharmaceutical products Chaudfontaine · balance sheet €1.44m
- Vabo Pharma Retail sale of pharmaceutical products Menen · balance sheet 960,813 €
Frequently asked questions about Rissphar
What is the revenue of Rissphar?
Rissphar files its accounts in a format where revenue is optional: it is not published for 2021.
What is the VAT number of Rissphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0678429579 for Rissphar, if the company is VAT-registered. Its company number (CBE) is 0678.429.579.
Where is the registered office of Rissphar?
According to the CBE register, the registered office of Rissphar is in 7812 Ath.
What is the equity of Rissphar?
At the close of the 2021 financial year, the equity of Rissphar amounts to 418,020 €, a solvency of 21.7% of total assets.
How many people work at Rissphar?
1.7 full-time equivalents on average according to the 2021 social balance sheet.
Who manages Rissphar?
The register lists 2 active mandates at Rissphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rissphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →